Process development and scale-up optimization of the SARS-CoV-2 receptor binding domain–based vaccine candidate, RBD219-N1C1

SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?

(2021) Saborni Chakraborty et al.   ADVANCED DRUG DELIVERY REVIEWS

Recombinant protein vaccines, a proven approach against coronavirus pandemics

(2021) Jeroen Pollet et al.   ADVANCED DRUG DELIVERY REVIEWS

Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics

(2021) J Peter Figueroa et al.   LANCET

International Collaboration to Ensure Equitable Access to Vaccines for COVID‐19: The ACT‐Accelerator and the COVAX Facility

(2021) MARK ECCLESTON‐TURNER et al.   MILBANK QUARTERLY

Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate

(2021) Wen-Hsiang Chen et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle

(2020) Hongzhou Lu et al.   JOURNAL OF MEDICAL VIROLOGY

Process Characterization and Biophysical Analysis for a Yeast-expressed Phlebotomus papatasi Salivary Protein (PpSP15) as a Leishmania vaccine candidate

(2020) Wen-Hsiang Chen et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

(2020) Qun Li et al.   NEW ENGLAND JOURNAL OF MEDICINE

Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2

(2020) Renhong Yan et al.   SCIENCE

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

(2020) Markus Hoffmann et al.   CELL

Structural basis of receptor recognition by SARS-CoV-2

(2020) Jian Shang et al.   NATURE

Developing a low-cost and accessible COVID-19 vaccine for global health

(2020) Peter J. Hotez et al.   PLoS Neglected Tropical Diseases

Lancet COVID-19 Commission Statement on the occasion of the 75th session of the UN General Assembly

(2020) Jeffrey D Sachs et al.   LANCET

Prospects for a safe COVID-19 vaccine

(2020) Barton F. Haynes et al.   Science Translational Medicine

Neutralizing antibodies for the treatment of COVID-19

(2020) Shibo Jiang et al.   Nature Biomedical Engineering

The EMBL-EBI search and sequence analysis tools APIs in 2019

(2019) Fábio Madeira et al.   NUCLEIC ACIDS RESEARCH

Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate

(2017) Wen-Hsiang Chen et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

The future of host cell protein (HCP) identification during process development and manufacturing linked to a risk-based management for their control

(2015) Daniel G. Bracewell et al.   BIOTECHNOLOGY AND BIOENGINEERING

Host cell protein testing by ELISAs and the use of orthogonal methods

(2014) Judith Zhu-Shimoni et al.   BIOTECHNOLOGY AND BIOENGINEERING

Recombinant protein subunit vaccine synthesis in microbes: a role for yeast?

(2014) Roslyn M. Bill   JOURNAL OF PHARMACY AND PHARMACOLOGY

Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate

(2013) Wen-Hsiang Chen et al.   Human Vaccines & Immunotherapeutics

COMMENTARY: Acceptable Levels of Endotoxin in Vaccine Formulations During Preclinical Research

(2010) Luis A. Brito et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Enhancing the Production of Fc Fusion Protein in Fed-Batch Fermentation of Pichia pastoris by Design of Experiments

(2007) Henry Lin et al.   BIOTECHNOLOGY PROGRESS